Molecular Mechanisms of Coffee on Prostate Cancer Prevention

Montenegro, Julia; Freitas-Silva, Otniel; Teodoro, Anderson Junger

doi:https://doi.org/10.1155/2022/3254420

BioMed Research International

On this page

Abstract Introduction Methods Conclusion Data Availability Disclosure Conflicts of Interest Acknowledgments References Copyright Related Articles

Special Issue

Cell Death Mechanisms in Cancer

View this Special Issue

Review Article | Open Access

Volume 2022 | Article ID 3254420 | https://doi.org/10.1155/2022/3254420

Molecular Mechanisms of Coffee on Prostate Cancer Prevention

Julia Montenegro,^1,2Otniel Freitas-Silva,^1,3and Anderson Junger Teodoro¹

Academic Editor: Ming Yi

Received24 Aug 2021

Accepted09 Apr 2022

Published22 Apr 2022

Abstract

Prostate cancer (PCa) is one of the most common types of cancer among men, and coffee is associated with a reduced risk of developing PCa. Therefore, we aim to review possible coffee molecular mechanisms that contribute to PCa prevention. Coffee has an important antioxidant capacity that reduces oxidative stress, leading to a reduced mutation in cells. Beyond direct antioxidant activity, coffee stimulates phase II enzymatic activity, which is related to the detoxification of reactive metabolites. The anti-inflammatory effects of coffee reduce tissue damage related to PCa development. Coffee induces autophagy, regulates the NF-κB pathway, and reduces the expression of iNOS and inflammatory mediators, such as TNF-α, IL-6, IL-8, and CRP. Also, coffee modulates transcriptional factors and pathways. It has been shown that coffee increases testosterone and reduces sex hormone-binding globulin, estrogen, and prostate-specific antigen. Coffee also enhances insulin resistance and glucose metabolism. All these effects may contribute to protection against PCa development.

1. Introduction

The prostate is a gland localized between men’s bladder and penis and surrounds the urethra. It secretes prostate fluid that protects sperm. Prostate cancer (PCa) develops when mutated semen-secreting prostate cells start proliferating uncontrollably. If PCa is not treated, it may metastasize, usually to lymph nodes, to hip bone, and then to other organs. Ordinarily, it is not diagnosed in the early stages because it is initially asymptomatic [1]. PCa is the second most common type of cancer among males, accounting for 14.1% of all cancers in men (WHO 2020).

Cancer, in general, develops due to successive mutations in genes, which alter cell morphology and physiology [2]. Oxidative stress leads to inflammation through redox pathways, increasing inflammatory marker circulation [3, 4]. The inflammatory response causes tissue injury and DNA damage [3, 5]. This disorder affects cell cycle and cell division, apoptosis signaling, and DNA repair mechanisms, leading to cancer [2].

Besides nonmodifiable risk factors, such as age, family history, and ethnicity, PCa development can also be influenced by diet and environmental factors, through epigenetics, which involves changes of gene transcription without any alteration in the nucleotide sequence [1]. Consumption of high content of natural phytochemicals from plants is associated with health benefits [4].

Coffee can be a major source of biochemical compounds [6] that can contribute to protection against PCa. In 2020, coffee consumption worldwide was 167.2 million bags (60 kg/bag) ((ICO) 2021). The main varieties produced are Arabica (Coffea arabica, 58.5%) and Robusta (Coffea canephora, 41.5%) ((ICO) 2021). Coffee has shown in vitro antiproliferative effects against PCa cell lines [7–11].

There are some meta-analyses with epidemiological data exploring the association of coffee intake and PCa risk [12–17]. However, no reviews so far have explored how coffee can have those beneficial effects on PCa. Therefore, the aim of this review is to detail molecular mechanisms that can be involved in the capacity of coffee and its bioactive compounds to prevent and treat PCa.

2. Methods

In this review, we searched at Web of Science, Scopus, and PubMed databases. The search terms included “Coffee” OR “Coffea arabica” OR “Coffea canephora” OR “chlorogenic acids” OR “CGA” OR “caffeine” on the title or abstract. Those were combined with specific terms of each possible effect with the Boolean operator “AND” for each search. For the antioxidant, the terms were “anti-oxidant” OR “oxidative stress” OR “Reactive oxygen species”. For the anti-inflammatory, the terms were “anti-inflammatory” OR “inflammation” OR “cytokines”. Other terms were “mutation”, OR “DNA damage” OR “transcriptional factors” OR “signaling pathways” OR “testosterone” OR “steroids hormones” OR “insulin resistance”.

Papers retrieved were filtered for original articles, published in English in the last 10 years. The association between coffee intake and prostate cancer risk has sometimes produced inconsistent results. To circumvent, summarize, and assess the quality of current evidence on the subject, observational studies on molecular mechanisms on existing findings were considered. Only papers produced in high impact factor journals were considered and used in this research. It was also observed the heterogeneity, evidence of small-study effects, and excess significance bias. Table 1 summarizes the relevant findings from 38 articles included in the present review.

3. Bioactive Compounds in Coffee

Coffee contains many well-known bioactive compounds that can be related to anticancer effects. Caffeine is a trimethylxanthine and is the major bioactive compound in coffee [18]. Virtually, all caffeine is absorbed and its main effect is the stimulation in the central nervous system and adenosine receptor inhibition [18, 19]. It has been observed that caffeine increases cancer cell death and protects against mutagenicity [20].

Chlorogenic acids (CGAs) are a group of polyphenols formed between transcinnamic and quinic acid [19, 21]. CGAs prevent free radical damage and modulate inflammation, regulation of glucose, and lipid metabolism [20]. Trigonelline is generated from the nicotinic acid and regulates key enzymes in glucose and lipid metabolism, preventing cell invasion and inhibiting cancer cell proliferation [18]. Diterpenes are the main lipidic fraction in coffee, primarily cafestol and kahweol, and have anticarcinogenic, antioxidant, and anti-inflammatory activity [18, 20]. Maillard reaction forms melanoidins during roasting, which has antioxidant, anti-inflammatory, and antimicrobial effects [18].

However, the chemical composition of coffee can vary depending on various factors. The first factor is the variety. Robusta coffee has more chlorogenic acids and caffeine than Arabica [22]. During coffee farming, the soil, altitude, sun exposure, rain, and temperature can affect coffee composition [23]. During processing, roasting, grinding, and brewing also affect the final composition [10].

4. Antioxidant Activity Induced by Coffee

Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are produced endogenously by mitochondrial respiration and exogenously by exposure to oxidizing agents [24]. Oxidative stress results from cellular production of oxidant molecules surpassing the capacity of antioxidants to overcome these damages and may lead to PCa development [25]. Oxidative stress causes the oxidation of crucial biomolecules, causing DNA damage and oxidizing key enzymes involved in gene expression [24].

Coffee presents high antioxidant capacity in vitro [10, 26, 27]. Coffee’s antioxidant compounds include caffeine, phenolic compounds (mostly CGAs), trigonelline, diterpenes (cafestol and kahweol), and melanoidins [20, 26]. A mechanism for coffee’s antioxidant activity is described in Figure 1.

Some studies have reported a significant increase in total plasma antioxidant capacity following coffee consumption, even after a single serving (200 or 400 mL). These effects of a single dose were lost in long term, but in recurrent consumption of medium roast coffee (150 mL/day), plasma antioxidant activity was increased by up to 26% [25].

Coffee significantly increased antioxidant response element (ARE) activation, which could induce the expression of genes related to the cellular antioxidant system [28, 29]. ARE proteins are a part of the complex antioxidant system that protects cells from oxidative damage by neutralizing free radicals and oxidizing agents [30]. ARE-related genes are in the cell defense promoter regions, which include phase II detoxifying enzymes and enzymes involved in antioxidant defense [29, 31].

Coffee consumption increases the intracellular activity of phase I (cytochrome P450) and II enzymes [6], such as glutathione reductase (GR), reduced glutathione (GSH), glutathione peroxidase (GPx), glutathione S-transferases (GST), superoxide dismutase (SOD), and catalase (CAT) ([32], Valadão [29, 30, 33–36]). This increase in GSH has been attributed to polyphenols [34].

It has been hypothesized that compounds with antioxidant properties generally increase the messenger RNA (mRNA) expression of antioxidant-related enzymes. But the expression of those enzymes can be downregulated in some antioxidant-treated cells because the compounds may have directly ameliorated the prevailing oxidative stress [34].

A low-molecular-weight coffee fraction supplementation in rats was able to reduce noncoding microRNA-124-3p and increase the expression of mRNA involved in GPx coding, raising the expression of this enzyme, probably due to caffeine [37]. Noncoding microRNA is an epigenetic factor, can act as tumor suppressors or oncogenes, and may be downregulated or upregulated in PCa. They are short regulatory RNA molecules that cannot be translated into amino acids and may disturb the mRNA purpose. This might influence RNA silencing and gene expression at posttranscriptional and translational levels [1].

Coffee has also been shown to inhibit oxidative stress through UDP-glucuronosyltransferases (UGT) activation, which catalyze the detoxification of reactive metabolites [38]; similar results were observed for caffeic acid [39]. Coffee reduced ROS production/concentration [38, 40, 41].

Antioxidant properties observed in coffee are mainly attributed to CGAs, which have one to two aromatic rings linked to hydroxyl groups and donate hydrogen atoms, reducing free radicals [24, 40, 42, 43]. Their oxidation products, phenoxyl radicals, are promptly stabilized by resonance stabilization. CGAs react with different sources of free radicals at a varied pace; their relative efficiency is species-specific [24].

Isolated kahweol protected mitochondria from redox stress and prevented the formation of ROS and RNS (De Oliveira, De Souza, and Fürstenau [44]).

5. Anti-Inflammation Effects

Inflammation is a physiological reaction to tissue damage induced by exogenous or endogenous agents. Exogen factors include pathogens, allergens, foreign bodies, and pernicious substances. Endogenous causes originate from cell signaling due to injured or malfunctioning tissues [24].

Inflammation may be related to PCa development because inflammatory cells are often present in the prostate microenvironment of adult men and are related to PCa precursor lesions, called proliferative inflammatory atrophy, which is abundant in cells that may be predisposed to genomic mutations, and inflammatory stress can provoke epigenetic changes, concomitant with the rupture of the epithelial barrier [45].

Coffee compounds can decrease chronic inflammation and, therefore, protect against DNA degradation, consequently decreasing the risk of disease [46]. The inflammation process is characterized by the raised production of proinflammatory cytokines, such as C-reactive protein (CRP), interleukins (IL), and tumor necrosis factors (TNF) [34].

A proposed mechanism for coffee’s anti-inflammatory effects is described in Figure 2. In animal models, green coffee intake reduced inflammatory markers, such as TNF-α [47, 48], IL-6, IL-10 [48], IL-1β, and Nos2 and reduced interstitial inflammatory index [47]. It has been observed in clinical trials that coffee intake over several weeks had a prevailing anti-inflammatory action evaluated by serum markers [49]. In addition to blood inflammatory markers, topical treatment of coffee and caffeine on mice’s paws displayed a considerable inhibition of the carrageenan-induced oedema development [27].

It has been observed that coffee can inhibit TNF-α-induced NF-κB activity and DNA-binding in PCa cells. Coffee also regulated the expression of inflammatory and cancer-related genes probably through the NF-κB signaling pathway. Coffee downregulated genes related to invasion (MMP9) and inflammation (NF-κB2, CD40, EDN1, and ICAM1) and upregulated genes related to the antioxidant system, such as NFE2L2, HMOX1, NQO1, and GCLC [8].

The TNF-α and IL-6 expressions were decreased by lightly roasted coffee extract, and the levels raised as roasting levels were exacerbated [34]. Inducible nitric oxide synthase (iNOS) expression declined, which produces proinflammatory mediators, such as NO [26, 34]. Coffee exhibited an inverse relation with CRP, IL-6, and TNFR2, with similar results both in caffeinated and decaffeinated coffee [50].

Autophagy selectively degrades cellular components to minimize cell injury [3]. Autophagy is related to inflammation and immunity regulation and has tumor-suppressive properties [51]. It has been observed that caffeinated and decaffeinated coffee can induce autophagy. Chronic and acute administration of coffee raised the autophagic flux in different tissues and reduced the content of the autophagic substrate sequestosome-1 (p62/SQSTM1). This occurs through lipidation of microtubule-associated protein 1 light chain 3 β (LC3B-I), rising the electrophoretic mobility in sodium dodecyl sulfate PAGE (SDS-PAGE), and converting to LC3B-II. Coffee also caused inhibition of the mammalian target of rapamycin complex 1 (mTORC1) enzymatic activity, probably related to deacetylation of cellular proteins [52]. Caffeine is known to induce hepatic autophagy, being hepatoprotective ([53, 54], Salomone, Galvano, and Li Volti [55]).

Indeed, caffeine is the main compound with overall anti-inflammatory activity in coffee and can reduce TNF-α and IL-6 production in a dose-dependent way. Caffeine can modulate nuclear factor-κB (NF-κB) activation [28], which provokes the expression of inflammatory genes, including iNOS, cyclooxygenase-2 (COX2), and cytokines [34].

Nonetheless, 26 anti-inflammatory metabolites have been identified in coffee [48]. CGAs decrease the generation of inflammatory mediators by inhibition of protein tyrosine phosphatase 1B (PTP1B), minimizing proinflammatory cytokine genes expression and regulating NF-κB activation [56]. As a result, COX is suppressed, causing a reduction of IL-6 and IL-8 and TNF-α release [28, 34]. Great CGA concentration represses IL-1B mRNA, provoking considerably less cell adhesion and inflammation [46].

Kahweol lessens COX2 and monocyte chemoattractant protein-1 (MCP-1) quantities, meaning it could be antiangiogenic. Kahweol also decreases iNOS in rats’ carrageenan paw oedema. During roasting, trigonelline is fractionated in nicotinic acid, which is a promising anti-inflammatory agent, as it diminishes MCP-1 and enhances adiponectin in adipocytes infused with TNF-α [46].

6. Protection against DNA Damage

Coffee’s antioxidant and anti-inflammatory effects result in protection against DNA damage. A proposed mechanism for coffee protection against DNA damage is described in Figure 3. It has been observed a reduction in spontaneous DNA strand breaks after only 2 hours of coffee consumption, with further decrease when more coffee was consumed [57]. Similar results were observed in 4 weeks [32, 58] and 8 weeks [31] of coffee intake.

These observations imply a defensive impact of coffee on DNA integrity. It has been observed that coffee reduced oxidative DNA damage induced by hydroxyl (OH°) radicals [43], H₂O₂ [33, 41], Ro photosensitizer [41], and benzo[α]pyrene (BaP) [38]. Additionally, coffee presents strong chemopreventive properties against DNA damage caused by aflatoxin, probably due to induction of GST [59].

Isolated compounds found in coffee, such as CGA and caffeine metabolites, reduced DNA single-strand breaks caused by ROS [60]. CGA isomers displayed a protective action against X-ray, H₂O₂, and NH₂Cl-induced DNA plasmid chromosome breaks [24].

Urinary 8-hydroxydeoxyguanosine excretion tended to reduce with coffee intake, which is a biomarker of systemic oxidative DNA damage and repair. This result was associated with lower serum ferritin and, indeed, coffee has iron-chelating properties [61]. Coffee and its diterpene components kahweol and cafestol raised the expression of DNA repair protein O6-methylguanine-DNA methyltransferase and some phase II enzymes [57].

Coffee constituents, such as CGAs, trigonelline, and kahweol, are regulators of the Nrf2/ARE signaling pathways ([57, 62], De Oliveira, De Souza, and Fürstenau 2020). It has been observed raised levels of Nrf2-dependent enzymes after consumption of coffees rich in CGA. Likewise, an inverse correlation between Nrf2 transcription and DNA strand breaks has been observed after coffee consumption [58].

Both Nrf2 and phosphorylated Nrf2 (pNrf2) are involved in the induction of Nrf2/ARE-dependent gene transcription. Alterations in Nrf2 translocation mediate the ARE-linked cytoprotective transcriptional response rather than a change in total Nrf2 concentration. There is evidence of pNrf2 translocation to the nucleus and an increase in pNrf2 with the decrease in Nrf2 due to coffee consumption [29, 31, 62].

7. Modulation of Transcriptional Factors

Coffee may prevent PCa development through modulation of transcriptional factors, which mechanism is shown in Figure 4. Some of those factors have already been discussed, such as NF-κB and Nrf2/ARE pathways. Coffee may also affect phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), activator protein 1 (AP-1), aryl hydrocarbon receptor (AhR), and mitogen-activated protein kinase (MAPK) pathways.

Coffee can downregulate PI3K/Akt signaling pathway [56], as well as its compounds, like caffeine [63] caffeic acid, and kahweol (De Oliveira, De Souza, and Fürstenau [44]). This pathway is protooncogenic and is responsible for metabolism, cell cycle, survival, and angiogenesis. It is frequently engaged in heme-oxygenase 1 (HO-1) expression and transcription of several kinds of cells. CGA promotes HO-1 expression and Nrf2 nuclear translocation, which might be related to PI3K/Akt signaling pathway [33].

The MAPK group comprises extracellular responsive kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK. MAPK signaling pathways are regulated by coffee [56] and kahweol (De Oliveira, De Souza, and Fürstenau [44]). There is an association between the restriction of cell growth and the lesser activation/phosphorylation of MAPKs, indicating a capacity to decrease cancer cell proliferation [64].

AhR has an adjusting role in the manifestation of CYP1A1 and CYP1A2 genes, which are involved in the metabolization of several substances [65]. Coffee activates AhR pathways genes, inducing UGT, which is related to detoxification and clearance of reactive metabolites [38, 66].

There is evidence that CGA secures against cancer caused by external factors. Its defensive actions can be associated with the omission of NF-κB, AP-1, and MAPK activation concerning ROS effects [64]. Specific effects of CGAs in transcriptional pathways leading to cancer growth suppression are reviewed elsewhere [21].

8. Controlling Steroid Metabolism

Historically, it was believed that androgens were involved in PCa development. However, more recent studies found no relation between testosterone levels and/or testosterone therapy and increased risk of PCa [67–73]. Furthermore, androgen deprivation therapy (ADT) is effective against most types of PCa, but its effect is probably related to androgen receptor (AR) expression, which is a well-established component of PCa [74–76].

Therefore, the relationship between androgenic hormones and PCa development is not completely understood. But coffee is involved in steroid metabolism, and a proposed mechanism is described in Figure 5.

Caffeinated coffee is associated with higher concentrations of total testosterone. This is probably related to sex hormone-binding globulin (SHBG), which is a sex hormone transport protein and functions as a regulator of their activity. Decreased SHBG may be linked to an elevated risk of PCa [50]. Coffee and caffeine are linked to greater SHBG concentration [50, 77, 78]. Caffeine and SHBG are primarily metabolized by the liver, so one possible explanation is that caffeine intake might cause SHBG rise by impacting its catabolism [50]. Another possibility is that caffeine increases hepatic SHBG production by upregulation adiponectin synthesis and decreasing Akt phosphorylation [77].

Besides that, studies have shown that coffee and caffeine can affect estrogen metabolism by inhibiting aromatase, the prime enzyme responsible for the transformation of androgen to estrogen [50, 79]. Serum estrogen and estrogen receptors (ER) are associated with PCa development, and the molecular mechanisms involved are reviewed elsewhere [80, 81]. Coffee intake is related to reduced levels of estrogen [50], possibly related to the presence of compounds with estrogenic activity in coffee [82]. Caffeine and caffeic acid reduced the ER expression [63].

Coffee oil has significantly decreased the prostate-specific antigen (PSA) compared to the control in vivo (Cueto et al. [83]). PSA is a specific PCa marker and used for diagnosis, and its concentration is usually remarkably high in PCa [84]. Therefore, a reduction in PSA levels suggests that coffee oil has defensive actions on the inflammatory status and against prostate hypertrophy. It has been hypothesized that the coffee oil effect was due to 5 alpha-reductase enzyme inhibition (Cueto et al. [83]).

AR has been associated with increased proliferation and altered migratory potential in PCa cells [74]. Coffee diterpenes (kahweol and cafestol) decreased the nuclear AR in AR-positive PCa cells, inhibiting their signals and inducing apoptosis. Coffee diterpenes also caused a reduction in CCR2 and CCR5, without raising their ligands (CCL2 and CCL5) [85].

9. Enhancing Insulin Resistance

Fasting serum insulin and insulin resistance are associated with PCa development. Insulin could act as a growth factor and probably raise the androgen entry in prostatic cells by reducing the effect of SHBG. Insulin resistance could raise insulin-like growth factor (IGF), which has mitogenic and antiapoptotic properties, which promote cell proliferation [86]. High circulating insulin also produces proinflammatory responses [4].

Besides its antioxidant and anti-inflammatory activities, coffee exerts specific effects that improve glucose and insulin status and is well recognized for preventing and treating type 2 diabetes mellitus (T2DM) [87, 88]. A summary of the mechanism of coffee on glucose metabolism is expressed in Figure 6. These effects are observed both in caffeinated and decaffeinated coffee; however, they might be more significant in decaffeinated coffee ([89, 90], Kumar [91]).

It has been observed that caffeinated coffee consumption reduces IGF-binding protein-3 (IGFBP-3), which extends IGF half-life. C-peptide also decreased due to coffee intake, which is a marker for insulin secretions, indicating lower insulin production and resistance [50]. Moreover, caffeic acid and caffeine reduced IGF-1 receptor expression [63].

It has been observed that incretins raised, and blood glucose reduced after coffee intake. Incretins, such as GLP-1 and GIP, are related to glucose reduction. Additionally, coffee has norharman β-carboline, which inhibits α-glucosidase activity, which lessens carbohydrate absorption, reducing postprandial glucose levels [89].

Caffeine acts as an antagonist of the A1 and A2 adenosine receptors, which in the skeletal muscle are related to insulin resistance [18, 19, 49]. Caffeine has a synergic effect with adrenergic hormones, which increases glucose intake by tissues. Most of the population quickly metabolizes caffeine; thus, it has acute effects. There is evidence that habitual caffeine intake leads to tolerance to these effects [90].

CGAs are probably responsible for the long-term effects. It has been hypothesized that CGA stimulates insulin release, being a secretagogue. CGA increased the expression of peroxisome proliferator-activated receptor-y (PPAR-y), which is essential in insulin sensitivity. Glucose transporter type 4 (GLUT4) also increased due to CGA, and its expression is stimulated by PPAR-y [92].

10. Conclusion

Coffee may reduce the risk of developing PCa through many molecular mechanisms. The ones are antioxidant and anti-inflammatory activities, protection against DNA damage, modulation of transcriptional factors, regulation through microRNA, enhancing steroid metabolism, and enhancing insulin resistance. However, studies vary on serving portions and it is not possible to determine an ideal coffee intake. Therefore, more molecular studies are fundamental to confirm such effects, determine intake recommendations, and assure safety. Coffee may impact PCa through other factors, but more studies are necessary to expand the knowledge on this area and to verify the real extension of the association of coffee consumption and its effects on PCa development.

Data Availability

The data used to support the findings of this study are included within the article.

Disclosure

The manuscript was presented as a Master’s thesis: Montenegro, Júlia. “Compostos bioativos, atividade antioxidante e atividade antiproliferativa em linhagens celulares de câncer de próstata de extratos de café obtidos por extração assistida por micro-ondas (MAE).” Master’s thesis, 2020. (http://www.unirio.br/ccbs/nutricao/ppgan_pt/dissertacoes-e-teses/dissertacoes-e-teses-defendidas/2020/2020/compostos-bioativos-atividade-antioxidante-e-atividade-antiproliferativa-em-linhagens-celulares-de-cancer-de-prostata-de-extratos-de-cafe-obtidos-por-extracao-assistida-por-micro-ondas-mae/view).

Conflicts of Interest

The authors declare no conflict of interest.

Acknowledgments

This research was funded by the FAPERJ grant numbers 202.073/2016 and 210.145/2016, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Grant 001, and Universidade Federal do Estado do Rio de Janeiro (UNIRIO).

References

M. M. Kgatle, A. A. Kalla, M. M. Islam, M. Sathekge, and R. Moorad, “Prostate cancer: epigenetic alterations, risk factors, and therapy,” Prostate Cancer, vol. 2016, 11 pages, 2016.
View at: Publisher Site | Google Scholar
S. H. Hassanpour and M. Dehghani, “Review of cancer from perspective of molecular,” Journal of Cancer Research and Practice, vol. 4, no. 4, pp. 127–129, 2017.
View at: Publisher Site | Google Scholar
C.-E. A. Kuo, S.-Y. Wu, C.-H. Lee et al., “Toona sinensis modulates autophagy and cytokines in lipopolysaccharide-induced RAW 264.7 macrophages,” Biomedicine & Pharmacotherapy, vol. 129, p. 110386, 2020.
View at: Publisher Site | Google Scholar
N. B. Poulsen, M. N. T. Lambert, and P. B. Jeppesen, “The effect of plant derived bioactive compounds on inflammation: a systematic review and meta-analysis,” Molecular Nutrition & Food Research, vol. 64, no. 18, p. 2000473, 2020.
View at: Publisher Site | Google Scholar
M. Murata, “Inflammation and cancer,” Environmental Health and Preventive Medicine, vol. 23, no. 1, pp. 1–8, 2018.
View at: Publisher Site | Google Scholar
S. Shaposhnikov, T. Hatzold, N. El Yamani et al., “Coffee and oxidative stress: a human intervention study,” European Journal of Nutrition, vol. 57, no. 2, pp. 533–544, 2018.
View at: Publisher Site | Google Scholar
D. Bauer, J. Abreu, N. Jordão, J. Rosa, O. Freitas-Silva, and A. Teodoro, “Effect of roasting levels and drying process of Coffea canephora on the quality of bioactive compounds and cytotoxicity,” International Journal of Molecular Sciences, vol. 19, no. 11, p. 3407, 2018.
View at: Publisher Site | Google Scholar
M. Kolberg, S. Pedersen, M. Mitake et al., “Coffee inhibits nuclear factor-kappa B in prostate cancer cells and xenografts,” The Journal of Nutritional Biochemistry, vol. 27, pp. 153–163, 2016.
View at: Publisher Site | Google Scholar
O. Lodise, K. Patil, I. Karshenboym, S. Prombo, C. Chukwueke, and S. Balakrishna Pai, “Inhibition of prostate cancer cells by 4,5-dicaffeoylquinic acid through cell cycle arrest,” Prostate Cancer, vol. 2019, 8 pages, 2019.
View at: Publisher Site | Google Scholar
J. Montenegro, L. S. D. Santos, R. G. G. De Souza et al., “Bioactive compounds, antioxidant activity and antiproliferative effects in prostate cancer cells of green and roasted coffee extracts obtained by microwave-assisted extraction (MAE),” Food Research International, vol. 140, article 110014, 2021.
View at: Publisher Site | Google Scholar
L. D. Souza, S. De, I. P. C. Horta et al., “Effect of the roasting levels of Coffea arabica L. extracts on their potential antioxidant capacity and antiproliferative activity in human prostate cancer cells,” RSC Advances, vol. 10, no. 50, pp. 30115–30126, 2020.
View at: Publisher Site | Google Scholar
S. Cao, L. Liu, X. Yin, Y. Wang, J. Liu, and Z. Lu, “Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies,” Carcinogenesis, vol. 35, no. 2, pp. 256–261, 2014.
View at: Publisher Site | Google Scholar
X. Chen, Y. Zhao, Z. Tao, and K. Wang, “Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis,” BMJ Open, vol. 11, no. 2, article e038902, 2021.
View at: Publisher Site | Google Scholar
H. Liu, H. Guang-Hui, X.-C. Wang et al., “Coffee consumption and prostate cancer risk: a meta-analysis of cohort studies,” Nutrition and Cancer, vol. 67, no. 3, pp. 392–400, 2015.
View at: Publisher Site | Google Scholar
Y. Lu, L. Zhai, J. Zeng et al., “Coffee consumption and prostate cancer risk: an updated meta-analysis,” Cancer Causes & Control, vol. 25, no. 5, pp. 591–604, 2014.
View at: Publisher Site | Google Scholar
C.-H. Park, S.-K. Myung, T.-Y. Kim et al., “Coffee consumption and risk of prostate cancer: a meta-analysis of epidemiological studies,” BJU International, vol. 106, no. 6, pp. 762–769, 2010.
View at: Publisher Site | Google Scholar
A. Wang, S. Wang, C. Zhu et al., “Coffee and cancer risk: a meta-analysis of prospective observational studies,” Scientific Reports, vol. 6, no. 1, p. 33711, 2016.
View at: Publisher Site | Google Scholar
G. L. Hu, X. Wang, L. Zhang, and M. H. Qiu, “The sources and mechanisms of bioactive ingredients in coffee,” Food & Function, vol. 10, no. 6, pp. 3113–3126, 2019.
View at: Publisher Site | Google Scholar
H. L. Wachamo, “Review on health benefit and risk of coffee consumption,” Med. Aromat. Plants, vol. 6, no. 4, pp. 1–12, 2017.
View at: Google Scholar
N. R. Jabir, M. T. Islam, S. Tabrez et al., “An insight towards anticancer potential of major coffee constituents,” BioFactors, vol. 44, no. 4, pp. 315–326, 2018.
View at: Publisher Site | Google Scholar
M. Lukitasari, D. A. Nugroho, and N. Widodo, “Chlorogenic acid: the conceivable chemosensitizer leading to cancer growth suppression,” Journal of Evidence-Based Integrative Medicine, vol. 23, 2018.
View at: Publisher Site | Google Scholar
S. I. Mussatto, E. M. S. Machado, S. Martins, and J. A. Teixeira, “Production, composition, and application of coffee and its industrial residues,” Food and Bioprocess Technology, vol. 4, no. 5, pp. 661–672, 2011.
View at: Publisher Site | Google Scholar
A. Hameed, S. A. Hussain, and H. A. R. Suleria, “Coffee bean-related agroecological factors affecting the coffee,” Co-Evolution of Secondary Metabolites, pp. 641–705, 2020.
View at: Publisher Site | Google Scholar
N. Liang and D. Kitts, “Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions,” Nutrients, vol. 8, no. 1, p. 16, 2016.
View at: Google Scholar
D. Martini, C. Del, M. Tassotti et al., “Coffee consumption and oxidative stress: a review of human intervention studies,” Molecules, vol. 21, no. 8, p. 979, 2016.
View at: Publisher Site | Google Scholar
D. M. López-Barrera, K. Vázquez-Sánchez, M. G. F. Loarca-Piña, and R. Campos-Vega, “Spent coffee grounds, an innovative source of colonic fermentable compounds, inhibit inflammatory mediators in vitro,” Food Chemistry, vol. 212, pp. 282–290, 2016.
View at: Publisher Site | Google Scholar
S. Pergolizzi, V. D’Angelo, M. Aragona et al., “Evaluation of antioxidant and anti-inflammatory activity of green coffee beans methanolic extract in rat skin,” Natural Product Research, vol. 34, no. 11, pp. 1535–1541, 2020.
View at: Publisher Site | Google Scholar
S. Choi, S. Jung, and K. Ko, “Effects of coffee extracts with different roasting degrees on antioxidant and anti-inflammatory systems in mice,” Nutrients, vol. 10, no. 3, p. 363, 2018.
View at: Publisher Site | Google Scholar
N. Volz, U. Boettler, S. Winkler et al., “Effect of coffee combining green coffee bean constituents with typical roasting products on the Nrf2/ARE pathway in vitro and in vivo,” Journal of Agricultural and Food Chemistry, vol. 60, no. 38, pp. 9631–9641, 2012.
View at: Publisher Site | Google Scholar
A. Priftis, A.-E. Angeli-Terzidou, A. Veskoukis, D. Spandidos, and D. Kouretas, “Cell-specific and roasting-dependent regulation of the Keap1/Nrf2 pathway by coffee extracts,” Molecular Medicine Reports, vol. 17, no. 6, pp. 8325–8331, 2018.
View at: Publisher Site | Google Scholar
G. Pahlke, E. Attakpah, G. Aichinger et al., “Dark coffee consumption protects human blood cells from spontaneous DNA damage,” Journal of Functional Foods, vol. 55, pp. 285–295, 2019.
View at: Publisher Site | Google Scholar
T. Bakuradze, N. Boehm, C. Janzowski et al., “Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: results from an intervention study,” Molecular Nutrition & Food Research, vol. 55, no. 5, pp. 793–797, 2011.
View at: Publisher Site | Google Scholar
D. Han, W. Chen, G. Xiaolong et al., “Cytoprotective effect of chlorogenic acid against hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells through PI3K/Akt-mediated Nrf2/HO-1 signaling pathway,” Oncotarget, vol. 8, no. 9, pp. 14680–14692, 2017.
View at: Publisher Site | Google Scholar
S. Jung, M. H. Kim, J. H. Park, Y. Jeong, and K. S. Ko, “Cellular antioxidant and anti-inflammatory effects of coffee extracts with different roasting levels,” Journal of Medicinal Food, vol. 20, no. 6, pp. 626–635, 2017.
View at: Publisher Site | Google Scholar
Q. A. Nogaim, L. S. P. Bugata, P. Pv et al., “Protective effect of Yemeni green coffee powder against the oxidative stress induced by ochratoxin A,” Toxicology Reports, vol. 7, pp. 142–148, 2020.
View at: Publisher Site | Google Scholar
V. Vicente, S. José, E. Y. Ishimoto, R. J. Cruz, C. D. S. Pereira, and E. A. F. D. S. Torres, “Increase of the activity of phase II antioxidant enzymes in rats after a single dose of coffee,” Journal of Agricultural and Food Chemistry, vol. 59, no. 20, pp. 10887–10892, 2011.
View at: Publisher Site | Google Scholar
V. Curti, M. Verri, A. Baldi et al., Eds., “In vivo modulatory effect of coffee (Coffea canephora var. Robusta) on the expression levels of murine microRNA-124-3p associated with antioxidant defenses,” eFood, vol. 1, no. 2, pp. 140–146, 2019.
View at: Publisher Site | Google Scholar
S. Kalthoff, S. Landerer, J. Reich, and C. P. Strassburg, “Protective effects of coffee against oxidative stress induced by the tobacco carcinogen benzo[α]pyrene,” Free Radical Biology and Medicine, vol. 108, pp. 66–76, 2017.
View at: Publisher Site | Google Scholar
S. Kalthoff, S. Paulusch, A. Rupp, S. Holdenrieder, G. Hartmann, and C. P. Strassburg, “The coffee ingredients caffeic acid and caffeic acid phenylethyl ester protect against irinotecan-induced leukopenia and oxidative stress response,” British Journal of Pharmacology, vol. 177, no. 18, pp. 4193–4208, 2020.
View at: Publisher Site | Google Scholar
M. Amigo-Benavent, S. Wang, R. Mateos, B. Sarriá, and L. Bravo, “Antiproliferative and cytotoxic effects of green coffee and yerba mate extracts, their main hydroxycinnamic acids, methylxanthine and metabolites in different human cell lines,” Food and Chemical Toxicology, vol. 106, no. 2017, pp. 125–138, 2017.
View at: Publisher Site | Google Scholar
J. Bravo, M. Leire Arbillaga, P. De Peña, and C. Cid, “Antioxidant and genoprotective effects of spent coffee extracts in human cells,” Food and Chemical Toxicology, vol. 60, pp. 397–403, 2013.
View at: Publisher Site | Google Scholar
K. Król, M. Gantner, A. Tatarak, and E. Hallmann, “The content of polyphenols in coffee beans as roasting, origin and storage effect,” European Food Research and Technology, vol. 246, no. 1, pp. 33–39, 2020.
View at: Publisher Site | Google Scholar
I. Tomac, M. Šeruga, and J. Labuda, “Evaluation of antioxidant activity of chlorogenic acids and coffee extracts by an electrochemical DNA-based biosensor,” Food Chemistry, vol. 325, article 126787, 2020.
View at: Publisher Site | Google Scholar
D. Oliveira, M. Roberto, I. C. C. De Souza, and C. R. Fürstenau, “Mitochondrial protection promoted by the coffee diterpene kahweol in methylglyoxal-treated human neuroblastoma SH-SY5Y cells,” Neurotoxicity Research, vol. 37, no. 1, pp. 100–110, 2020.
View at: Publisher Site | Google Scholar
K. S. Sfanos, S. Yegnasubramanian, W. G. Nelson, and A. M. De Marzo, “The inflammatory microenvironment and microbiome in prostate cancer development,” Nature Reviews Urology, vol. 15, no. 1, pp. 11–24, 2018.
View at: Publisher Site | Google Scholar
N. J. Frost-Meyer and J. V. Logomarsino, “Impact of coffee components on inflammatory markers: a review,” Journal of Functional Foods, vol. 4, no. 4, pp. 819–830, 2012.
View at: Publisher Site | Google Scholar
O. D. Alamri, R. S. Albeltagy, A. M. A. Akabawy et al., “Investigation of antioxidant and anti-inflammatory activities as well as the renal protective potential of green coffee extract in high fat-diet/streptozotocin-induced diabetes in male albino rats,” Journal of Functional Foods, vol. 71, article 103996, 2020.
View at: Publisher Site | Google Scholar
K.-V. Ho, K. L. Schreiber, J. Park et al., “Identification and quantification of bioactive molecules inhibiting pro-inflammatory cytokine production in spent coffee grounds using metabolomics analyses,” Frontiers in Pharmacology, vol. 11, p. 229, 2020.
View at: Publisher Site | Google Scholar
C. Paiva, B. Beserra, C. Reis, J. Dorea, T. Da Costa, and A. Amato, “Consumption of coffee or caffeine and serum concentration of inflammatory markers: a systematic review,” Critical Reviews in Food Science and Nutrition, vol. 59, no. 4, pp. 652–663, 2019.
View at: Publisher Site | Google Scholar
D. Hang, A. S. Kværner, W. Ma et al., “Coffee consumption and plasma biomarkers of metabolic and inflammatory pathways in US health professionals,” The American Journal of Clinical Nutrition, vol. 109, no. 3, pp. 635–647, 2019.
View at: Publisher Site | Google Scholar
Z. Zhong, E. Sanchez-Lopez, and M. Karin, “Autophagy, inflammation, and immunity: a troika governing cancer and its treatment,” Cell, vol. 166, no. 2, pp. 288–298, 2016.
View at: Publisher Site | Google Scholar
F. Pietrocola, S. A. Malik, G. Mariño et al., “Coffee induces autophagy in vivo,” Cell Cycle, vol. 13, no. 12, pp. 1987–1994, 2014.
View at: Publisher Site | Google Scholar
K. Ray, “Caffeine is a potent stimulator of autophagy to reduce hepatic lipid content—a coffee for NAFLD?” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 10, pp. 563–563, 2013.
View at: Publisher Site | Google Scholar
R. A. Sinha, B. L. Farah, B. K. Singh et al., “Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice,” Hepatology, vol. 59, no. 4, pp. 1366–1380, 2014.
View at: Publisher Site | Google Scholar
F. Salomone, F. Galvano, and G. L. Volti, “Molecular bases underlying the hepatoprotective effects of coffee,” Nutrients, vol. 9, no. 1, p. 85, 2017.
View at: Publisher Site | Google Scholar
H.-C. Huang, C.-M. Wei, J.-H. Siao et al., “Supercritical fluid extract of spent coffee grounds attenuates melanogenesis through downregulation of the PKA, PI3K/Akt, and MAPK signaling pathways,” Evidence-based Complementary and Alternative Medicine, vol. 2016, 11 pages, 2016.
View at: Publisher Site | Google Scholar
T. Bakuradze, R. Lang, T. Hofmann et al., “Coffee consumption rapidly reduces background DNA strand breaks in healthy humans: results of a short-term repeated uptake intervention study,” Molecular Nutrition & Food Research, vol. 60, no. 3, pp. 682–686, 2016.
View at: Publisher Site | Google Scholar
T. Bakuradze, R. Lang, T. Hofmann et al., “Consumption of a dark roast coffee decreases the level of spontaneous DNA strand breaks: a randomized controlled trial,” European Journal of Nutrition, vol. 54, no. 1, pp. 149–156, 2015.
View at: Publisher Site | Google Scholar
F. Ferk, W. W. Huber, B. Grasl-Kraupp et al., “Protective effects of coffee against induction of DNA damage and pre-neoplastic foci by aflatoxin B1,” Molecular Nutrition & Food Research, vol. 58, no. 2, pp. 229–238, 2014.
View at: Publisher Site | Google Scholar
M. A. Rathod, D. Patel, A. Das, S. R. Tipparaju, S. S. Shinde, and R. F. Anderson, “Inhibition of radical-induced DNA strand breaks by water-soluble constituents of coffee: phenolics and caffeine metabolites,” Free Radical Research, vol. 47, no. 6-7, pp. 480–487, 2013.
View at: Publisher Site | Google Scholar
A. Hori, H. Kasai, K. Kawai et al., “Coffee intake is associated with lower levels of oxidative DNA damage and decreasing body iron storage in healthy women,” Nutrition and Cancer, vol. 66, no. 6, pp. 964–969, 2014.
View at: Publisher Site | Google Scholar
U. Boettler, K. Sommerfeld, N. Volz et al., “Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression,” The Journal of Nutritional Biochemistry, vol. 22, no. 5, pp. 426–440, 2011.
View at: Publisher Site | Google Scholar
A. H. Rosendahl, C. M. Perks, L. Zeng et al., “Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor I receptor levels in human breast cancer,” Clinical Cancer Research, vol. 21, no. 8, pp. 1877–1887, 2015.
View at: Publisher Site | Google Scholar
A. Palmioli, C. Ciaramelli, R. Tisi et al., “Natural compounds in cancer prevention: effects of coffee extracts and their main polyphenolic component, 5-O-caffeoylquinic acid, on oncogenic Ras proteins,” Chemistry-An Asian Journal, vol. 12, no. 18, pp. 2457–2466, 2017.
View at: Publisher Site | Google Scholar
A. T. Nordestgaard, S. Stender, B. G. Nordestgaard, and A. Tybjærg-Hansen, “Coffee intake protects against symptomatic gallstone disease in the general population: a Mendelian randomization study,” Journal of Internal Medicine, vol. 287, no. 1, pp. 42–53, 2020.
View at: Publisher Site | Google Scholar
G. Toydemir, L. M. P. Loonen, P. B. Venkatasubramanian, J. J. Mes, J. M. Wells, and N. De Wit, “Coffee induces AHR- and Nrf2-mediated transcription in intestinal epithelial cells,” Food Chemistry, vol. 341, article 128261, 2021.
View at: Publisher Site | Google Scholar
P. Boyle, A. Koechlin, M. Bota et al., “Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis,” BJU International, vol. 118, no. 5, pp. 731–741, 2016.
View at: Publisher Site | Google Scholar
A. L. Kaplan, J. C. Hu, A. Morgentaler, J. P. Mulhall, C. C. Schulman, and F. Montorsi, “Testosterone therapy in men with prostate cancer,” European Urology, vol. 69, no. 5, pp. 894–903, 2016.
View at: Publisher Site | Google Scholar
M. Khera, D. Crawford, A. Morales, A. Salonia, and A. Morgentaler, “A new era of testosterone and prostate cancer: from physiology to clinical implications,” European Urology, vol. 65, no. 1, pp. 115–123, 2014.
View at: Publisher Site | Google Scholar
S. Loeb, Y. Folkvaljon, J.-E. Damber, J. Alukal, M. Lambe, and P. Stattin, “Testosterone replacement therapy and risk of favorable and aggressive prostate cancer,” Journal of Clinical Oncology, vol. 35, no. 13, pp. 1430–1436, 2017.
View at: Publisher Site | Google Scholar
K. M. Rodriguez, A. W. Pastuszak, and M. Khera, “The role of testosterone therapy in the setting of prostate cancer,” Current Urology Reports, vol. 19, no. 8, p. 67, 2018.
View at: Publisher Site | Google Scholar
T. J. Walsh, M. M. Shores, C. A. Krakauer et al., “Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels,” PLoS One, vol. 13, no. 6, article e0199194, 2018.
View at: Publisher Site | Google Scholar
A. Yassin, K. Alrumaihi, R. Alzubaidi, S. Alkadhi, and A. Al Ansari, “Testosterone, testosterone therapy and prostate cancer,” The Aging Male, vol. 22, no. 4, pp. 219–227, 2019.
View at: Publisher Site | Google Scholar
D. Leach and G. Buchanan, “Stromal androgen receptor in prostate cancer development and progression,” Cancers, vol. 9, no. 12, p. 10, 2017.
View at: Publisher Site | Google Scholar
V. Mollica, V. Di Nunno, A. Cimadamore et al., “Molecular mechanisms related to hormone inhibition resistance in prostate cancer,” Cell, vol. 8, no. 1, p. 43, 2019.
View at: Publisher Site | Google Scholar
S. Ramalingam, V. P. Ramamurthy, and V. C. O. Njar, “Dissecting major signaling pathways in prostate cancer development and progression: mechanisms and novel therapeutic targets,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 166, pp. 16–27, 2017.
View at: Publisher Site | Google Scholar
L. Briansó-Llort, L. Fuertes-Rioja, L. Ramos-Perez, C. Hernandez, R. Simó, and D. M. Selva, “Caffeine upregulates hepatic sex hormone-binding globulin production by increasing adiponectin through AKT/FOXO1 pathway in white adipose tissue,” Molecular Nutrition & Food Research, vol. 64, no. 17, p. 1901253, 2020.
View at: Publisher Site | Google Scholar
T. Frey, E. A. Platz, N. Kanarek, G. Bradwin, A. S. Dobs, and S. Rohrmann, “Consumption of caffeinated beverages and serum concentrations of sex steroid hormones in US men,” Cancer Causes & Control, vol. 29, no. 1, pp. 157–166, 2018.
View at: Publisher Site | Google Scholar
A. Lafranconi, A. Micek, F. Galvano et al., “Coffee decreases the risk of endometrial cancer: a dose–response meta-analysis of prospective cohort studies,” Nutrients, vol. 9, no. 11, p. 1223, 2017.
View at: Publisher Site | Google Scholar
H. Bonkhoff, “Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression,” The Prostate, vol. 78, no. 1, pp. 2–10, 2018.
View at: Publisher Site | Google Scholar
R. W. Dobbs, N. R. Malhotra, D. T. Greenwald, A. Y. Wang, G. S. Prins, and M. R. Abern, “Estrogens and prostate cancer,” Prostate Cancer and Prostatic Diseases, vol. 22, no. 2, pp. 185–194, 2019.
View at: Publisher Site | Google Scholar
R. Kiyama, “Estrogenic activity of coffee constituents,” Nutrients, vol. 11, no. 6, p. 1401, 2019.
View at: Publisher Site | Google Scholar
K. A. G. Cueto, J. A. C. Macalincag, R. B. Aseremo et al., “Inhibitory effect of Coffea arabica bean in testosterone induced prostatic hyperplasia in Sprague-Dawley rats,” Asia Pacific Journal of Multidisciplinary Research, vol. 4, no. 2, 2016.
View at: Google Scholar
M. Logozzi, D. F. Angelini, E. Iessi et al., “Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients,” Cancer Letters, vol. 403, pp. 318–329, 2017.
View at: Publisher Site | Google Scholar
H. Iwamoto, K. Izumi, A. Natsagdorj et al., “Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells,” The Prostate, vol. 79, no. 5, pp. 468–479, 2019.
View at: Publisher Site | Google Scholar
S. Saboori, E. Y. Rad, M. Birjandi, S. Mohiti, and E. Falahi, “Serum insulin level, HOMA-IR and prostate cancer risk: a systematic review and meta-analysis,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 13, no. 1, pp. 110–115, 2019.
View at: Publisher Site | Google Scholar
S. Casal and I. Rebelo, “Coffee: a dietary intervention on type 2 diabetes?” Current Medicinal Chemistry, vol. 24, no. 4, pp. 376–383, 2017.
View at: Publisher Site | Google Scholar
G. Williamson, “Protection against developing type 2 diabetes by coffee consumption: assessment of the role of chlorogenic acid and metabolites on glycaemic responses,” Food & Function, vol. 11, no. 6, pp. 4826–4833, 2020.
View at: Publisher Site | Google Scholar
C. E. G. Reis, C. L. D. S. Paiva, S. Paiva et al., “Decaffeinated coffee improves insulin sensitivity in healthy men,” British Journal of Nutrition, vol. 119, no. 9, pp. 1029–1038, 2018.
View at: Publisher Site | Google Scholar
C. E. G. Reis, J. G. Dórea, and T. H. M. Da Costa, “Effects of coffee consumption on glucose metabolism: a systematic review of clinical trials,” Journal of Traditional and Complementary Medicine, vol. 9, no. 3, pp. 184–191, 2019.
View at: Publisher Site | Google Scholar
K. Singh, C. C. Amit, R. Kumar et al., “Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency,” Nutrients, vol. 11, no. 9, p. 2216, 2019.
View at: Publisher Site | Google Scholar
G. Sanchez-Delgado and E. Ravussin, “Assessment of energy expenditure: are calories measured differently for different diets?” Current Opinion in Clinical Nutrition & Metabolic Care, vol. 23, no. 5, pp. 312–318, 2020.
View at: Publisher Site | Google Scholar
S.-R. Park, S.-R. Kim, I.-S. Hong, and H.-Y. Lee, “A novel therapeutic approach for colorectal cancer stem cells: blocking the PI3K/Akt signaling axis with caffeic acid,” Frontiers in Cell and Developmental Biology, vol. 8, p. 1636, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Julia Montenegro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1494

Downloads

1106

Citations